Bioage Labs Inc/$BIOA
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Bioage Labs Inc
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
Ticker
$BIOA
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
63
ISIN
US09077V1008
Website
Bioage Labs Inc Metrics
BasicAdvanced
$157M
-
-$3.69
-
-
Price and volume
Market cap
$157M
52-week high
$4.70
52-week low
$2.88
Average daily volume
265K
Financial strength
Current ratio
13.683
Quick ratio
13.518
Long term debt to equity
1.153
Total debt to equity
3.293
Interest coverage (TTM)
-58.24%
Profitability
EBITDA (TTM)
-81.656
Gross margin (TTM)
-665.61%
Net profit margin (TTM)
-4,896.28%
Operating margin (TTM)
-5,639.35%
Revenue per employee (TTM)
$20,000
Management effectiveness
Return on assets (TTM)
-19.54%
Return on equity (TTM)
-30.20%
Valuation
Price to revenue (TTM)
58.171
Price to book
0.5
Price to tangible book (TTM)
0.5
Price to free cash flow (TTM)
-1.563
Free cash flow yield (TTM)
-63.98%
Free cash flow per share (TTM)
-280.24%
Growth
Earnings per share change (TTM)
-90.62%
Bioage Labs Inc News
AllArticlesVideos
BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank
GlobeNewsWire·7 hours ago
BioAge Labs to Present at Upcoming Investor Conferences
GlobeNewsWire·3 weeks ago
BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Bioage Labs Inc stock?
Bioage Labs Inc (BIOA) has a market cap of $157M as of June 17, 2025.
What is the P/E ratio for Bioage Labs Inc stock?
The price to earnings (P/E) ratio for Bioage Labs Inc (BIOA) stock is 0 as of June 17, 2025.
Does Bioage Labs Inc stock pay dividends?
No, Bioage Labs Inc (BIOA) stock does not pay dividends to its shareholders as of June 17, 2025.
When is the next Bioage Labs Inc dividend payment date?
Bioage Labs Inc (BIOA) stock does not pay dividends to its shareholders.
What is the beta indicator for Bioage Labs Inc?
Bioage Labs Inc (BIOA) does not currently have a Beta indicator.